NCT06956950View on ClinicalTrials.gov

Magnesium Sulfate in Addition to Bupivacaine in Ultrasound-guided Transmuscular Quadratus Lumborum Block for Post-Operative Analgesia After Total Hip Arthroplasty

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

October 9, 2025

Study Completion Date

November 30, 2025

Conditions

Pain Score Reduction

Interventions

DRUG

Bupivacaine + Magnesium sulfate

ultrasound-guided transmuscular quadratus lumborum block using 25 ml of 0.25% bupivacaine + 5 ml 10% magnesium sulfate

DRUG

Bupivacaine + saline

ultrasound-guided transmuscular quadratus lumborum block using 25 ml of 0.25% bupivacaine + 5 ml normal saline

Trial Locations (1)

31527

RECRUITING

Faculty of medicine, Tanta

All Listed Sponsors

lead

Tanta University

OTHER

NCT06956950 - Magnesium Sulfate in Addition to Bupivacaine in Ultrasound-guided Transmuscular Quadratus Lumborum Block for Post-Operative Analgesia After Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter